It's not socialism. Again...refer to the definition.

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks OMO #6013
Quote:
It's not socialism. Again...refer to the definition. Individuals continually attempt to adjust the meaning to fit their argument.


I say that you're doing exactly what you accuse me of. Any definition of socialism that limits itself to gov. control of the means of production is.............................incomplete.

And none of Sanders positions talk about the 'means of production', other than in the context of regulations and taxes.

Gov. ownership? I haven't heard that. You?

You absolutely know that there is a social/welfare component to socialism. Almost all of the opponents to SS, Medicare, Medicare and the ACA has labeled them as socialistic.

GOP efforts to privatize those programs always condemn the socialist aspect of them the way they are.

I don't often take Republicans at their word, or for their accurate understanding of matters, But here I defer to them!

You know we've been talking about social programs, SS and Medicare. Maybe you should take the word of Republicans going back 8O years at least.

Quote:
There has been a lot of misinformation promulgated concerning the possibility of the enactment of national health care on television, newspapers, and especially the internet.

For a change of pace, let us review a few facts that we should all know.

When the FDR administration proposed a national Social Security system, the Republican Party vehemently opposed it. When the Johnson administration proposed a national Medicare system, the Republican Party vehemently opposed it. Both programs were labeled as Socialism and strongly denounced but, which now, very few people would want eliminated.

Now, the Obama Administration is trying to improve the ever increasingly expensive health care system, which is uniquely in place in the U.S., and the Socialism label is again being used.

I say "uniquely" because every other industrialized nation in the world, even those who are far less well off than we are here, have national health care systems. If they can afford it, then we certainly can.

There's a reason why 47 million working Americans don't have medical insurance, and it's because it costs way too much for them or their employers to pay for it, and it is the fastest growing expenditure in our economy.

The new system is specifically intended for the middle class. Remember, the Medicaid program provides free health care for the unemployed and underemployed poor in our country.

The time has come for health care in our nation to get off the backs of all of our citizens."

http://www.nj.com/cranford/index.ssf/2009/08/...again.html


Germany became the first nation in the world to adopt an old-age social insurance program in 1889, designed by Germany's Chancellor, Otto von Bismarck. The idea was first put forward, at Bismarck's behest, in 1881 by Germany's Emperor, William the First, in a ground-breaking letter to the German Parliament. William wrote: ". . .those who are disabled from work by age and invalidity have a well-grounded claim to care from the state."

Bismarck was motivated to introduce social insurance in Germany both in order to promote the well-being of workers in order to keep the German economy operating at maximum efficiency, and to stave-off calls for more radical socialist alternatives. Despite his impeccable right-wing credentials, Bismarck would be called a socialist for introducing these programs, as would President Roosevelt 70 years later. In his own speech to the Reichstag during the 1881 debates, Bismarck would reply: "Call it socialism or whatever you like. It is the same to me."

The German system provided contributory retirement benefits and disability benefits as well. Participation was mandatory and contributions were taken from the employee, the employer and the government. Coupled with the workers' compensation program established in 1884 and the "sickness" insurance enacted the year before, this gave the Germans a comprehensive system of income security based on social insurance principles.

(They would add unemployment insurance in 1927, making their system complete.)


https://www.ssa.gov/history/ottob.html

“The debate over Senator Sanders’ socialism is rich with paradoxes. Senator Sanders is not a proponent of socialism, and that is a good thing, for true socialism, whenever and wherever it has been tried, ended in disaster. Nor is America the bastion of capitalism that some make it out to be. In fact, U.S. taxes, spending, and regulation are quite high when compared to truly economically free countries. America’s is a mixed economy and so are Scandinavian countries’. It is the mixture that differs.

As someone who grew up under socialism and is still, barely, in his 30s, I hope to relate a few ideas to the young people who are “feeling the Bern.” First, Sanders is not a socialist, but a social democrat. Second, the United States does not have a strictly capitalist economy, but a mixed one.

As such, it combines a high level of private ownership of capital and the means of production with relatively onerous regulation and taxation. Third, to the extent that what anti-capitalist Sanders supporters really want is a Scandinavian-style social democracy, with its high level of wealth redistribution and income equality, they should consider that even some of the most socially democratic countries on earth are, in one crucial way, more capitalist than the United States.”

http://www.theatlantic.com/international/arch...sm/471630/ [/quote]

Quote:
Include hospitals and overall facilities. This seems to be ignored by many. I believe in having a two-tier system....similar to France and Spain. France despises socialized medicine et al...as they should.


Avoids answering the question. why despite the 2nd highest outlays for healthcare why is the U.S. not in the top 10? and what are out 'outcomes', are prevention and our life expectancies also not in the top tier? Telling me that an entire nation despise something tells me you've taken some anecdotes and extrapolated them as representative.


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Spruce Point's Strong Sell Rating Casts Doubt on Construction Partners

Updated Category News Views 116

Spruce Point's Strong Sell Opinion on Construction Partners Inc Spruce Point Capital Management has recently issued a compelling report regarding Construction Partners Inc (NASDAQ: ROAD), a company recognized for its expertise in infrastructure and road construction. This report voices a strong sell recommendation, reflecting serious concerns over the company's current...

Continue Reading
Celebrating Excellence in Healthcare: Press Ganey's Honorees

Updated Category News Views 344

Celebrating the Executive Human Experience Award Winners Press Ganey, an industry leader dedicated to enhancing healthcare experiences, recently celebrated exceptional achievements in the field. During its annual conference, the Executive Human Experience Awards recognized extraordinary contributions from professionals and organizations that prioritize patient, consumer,...

Continue Reading
Commercial Vehicle Market Growth Driven by Technology Advancements

Updated Category News Views 122

Commercial Vehicle Market Growth and Projections The global commercial vehicle market is on an upward trajectory, with sales expected to reach 3.5 million units by 2025. The anticipated Year-over-Year (YoY) growth of 4.4% from 2024 highlights the increasing demand for medium and heavy commercial vehicles. This trend is being driven by several factors, including...

Continue Reading
Atos Receives Prestigious EcoVadis Platinum Medal Again

Updated Category News Views 195

Let’s not beat around the bush—Atos is doing something right in the sustainability game. They've bagged the EcoVadis Platinum Medal for five years running. Yep, that’s a serious flex in today’s corporate climate where ‘green’ isn’t just a buzzword; it’s almost an obligation if you want to stay relevant. The Metrics Behind Atos's Shine Scoring a...

Continue Reading
Power Metallic Mines Updates Shareholder Meeting Outcomes

Updated Category News Views 157

Power Metallic Mines Reports on AGSM Meeting Outcomes Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) expressed satisfaction with the voting outcomes from its Annual General and Special Meeting ("AGSM") that took place recently. The meeting gathered shareholders to discuss essential business items and elect members to the Board of...

Continue Reading